These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3377868)

  • 1. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging.
    Robbins ML; Kornguth SE; Bell CL; Kalinke T; England D; Turski P; Graziano FM
    Arthritis Rheum; 1988 May; 31(5):623-31. PubMed ID: 3377868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers.
    Bell CL; Partington C; Robbins M; Graziano F; Turski P; Kornguth S
    Arthritis Rheum; 1991 Apr; 34(4):432-41. PubMed ID: 1901492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
    Sabbadini MG; Manfredi AA; Bozzolo E; Ferrario L; Rugarli C; Scorza R; Origgi L; Vanoli M; Gambini O; Vanzulli L; Croce D; Campana A; Messa C; Fazio F; Tincani A; Anzola G; Cattaneo R; Padovani A; Gasparotti R; Gerli R; Quartesan R; Piccirilli M; Farsi A; Emmi E; Passaleva A
    Lupus; 1999; 8(1):11-9. PubMed ID: 10025594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
    Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
    Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies.
    Costallat LT; de Oliveira RM; Santiago MB; Cossermelli W; Samara AM
    Clin Rheumatol; 1990 Dec; 9(4):489-97. PubMed ID: 2088646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychiatric symptoms and findings in systemic lupus erythematosus ].
    Lund C; Gjerstad L
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2043-5. PubMed ID: 9235685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies.
    Fields RA; Sibbitt WL; Toubbeh H; Bankhurst AD
    Ann Rheum Dis; 1990 Feb; 49(2):114-7. PubMed ID: 2317112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal lupus erythematosus with a high anticardiolipin antibody titer. Unusual variant of neonatal lupus erythematosus or early-onset systemic lupus erythematosus?
    Katayama I; Kondo S; Kawana S; Nishioka K; Nishiyama S
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):490-2. PubMed ID: 2789235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of neuropsychiatric manifestations in systemic lupus erythematosus.
    Fujieda Y
    Immunol Med; 2020 Dec; 43(4):135-141. PubMed ID: 32459601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral systemic lupus erythematosus with apnea in a patient with cardiolipin antibodies and oligoclonal bands.
    Herkes GK; Cohen MG; Podgorski M; Webb J
    J Rheumatol; 1988 Mar; 15(3):523-4. PubMed ID: 3379629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features.
    Chancellor AM; Cull RE; Kilpatrick DC; Warlow CP
    J Neurol; 1991 Oct; 238(7):401-7. PubMed ID: 1960545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus.
    Ritchlin CT; Chabot RJ; Alper K; Buyon J; Belmont HM; Roubey R; Abramson SB
    Arthritis Rheum; 1992 Nov; 35(11):1330-42. PubMed ID: 1445450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
    Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
    Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
    Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement.
    Cohen D; Rijnink EC; Nabuurs RJ; Steup-Beekman GM; Versluis MJ; Emmer BJ; Zandbergen M; van Buchem MA; Allaart CF; Wolterbeek R; Bruijn JA; van Duinen SG; Huizinga TW; Bajema IM
    Rheumatology (Oxford); 2017 Jan; 56(1):77-86. PubMed ID: 28028157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-twin control study on cerebral manifestations of systemic lupus erythematosus.
    Kinnunen E; Järvinen P; Ketonen L; Sepponen R
    Acta Neurol Scand; 1993 Dec; 88(6):422-6. PubMed ID: 8116344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.
    Harris EN; Gharavi AE; Boey ML; Patel BM; Mackworth-Young CG; Loizou S; Hughes GR
    Lancet; 1983 Nov; 2(8361):1211-4. PubMed ID: 6139567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.